Related Experiment Video
Updated: Aug 24, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
DNA repair pathways in drug resistance in melanoma
Penny A Bradbury1, Mark R Middleton
1Cancer Research UK Medical Oncology Unit, Churchill Hospital, Oxford, UK.
Abstract:
Metastatic melanoma has a poor prognosis due to resistance to multiple chemotherapy regimens. The mainstay of treatment remains dacarbazine, with cisplatin being a commonly used alternative. Melanoma displays marked resistance to the DNA-damaging effects of these drugs. Intrinsic and acquired resistance involves multiple cellular pathways of damage recognition, repair and apoptosis. Increased understanding of these pathways is identifying novel targets that it is hoped will make inroads into the treatment of this lethal disease.
Insights
Metastatic melanoma is hard to treat due to drug resistance. Understanding cellular pathways involved in chemotherapy resistance may reveal new therapeutic targets for this deadly cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Metastatic melanoma presents a significant clinical challenge with a poor prognosis.
- Current treatments like dacarbazine and cisplatin are often ineffective due to inherent drug resistance in melanoma cells.
Purpose of the Study:
- To explore the molecular mechanisms underlying chemotherapy resistance in metastatic melanoma.
- To identify novel therapeutic targets for improving treatment outcomes in advanced melanoma.
Main Methods:
- Review of existing literature on melanoma chemoresistance.
- Analysis of cellular pathways involved in DNA damage recognition, repair, and apoptosis.
- Investigation of intrinsic and acquired resistance mechanisms.
Main Results:
- Melanoma exhibits substantial resistance to DNA-damaging chemotherapies.
- Multiple cellular pathways contribute to both intrinsic and acquired drug resistance.
- Understanding these resistance pathways is crucial for therapeutic development.
Conclusions:
- Chemotherapy resistance is a major obstacle in treating metastatic melanoma.
- Further research into cellular resistance mechanisms can uncover novel therapeutic strategies.
- Targeting these pathways holds promise for advancing melanoma treatment.
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Nucleotide Excision Repair
Treatment Resistant Cancers
Overview of DNA Repair
Chemically...
Overview of DNA Repair
Chemically...

